Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis J Hemelaar, R Elangovan, J Yun, L Dickson-Tetteh, I Fleminger, S Kirtley, ... The Lancet infectious diseases 19 (2), 143-155, 2019 | 333 | 2019 |
Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study J Gregson, M Tang, N Ndembi, RL Hamers, SY Rhee, VC Marconi, ... The Lancet infectious diseases 16 (5), 565-575, 2016 | 280 | 2016 |
Global disparities in SARS-CoV-2 genomic surveillance AF Brito, E Semenova, G Dudas, GW Hassler, CC Kalinich, MUG Kraemer, ... Nature communications 13 (1), 7003, 2022 | 193 | 2022 |
Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe LM Hofstra, N Sauvageot, J Albert, I Alexiev, F Garcia, D Struck, ... Clinical infectious diseases 62 (5), 655-663, 2016 | 189 | 2016 |
Tracking the international spread of SARS-CoV-2 lineages B. 1.1. 7 and B. 1.351/501Y-V2 with grinch Á O'Toole, V Hill, OG Pybus, A Watts, II Bogoch, K Khan, JP Messina, ... Wellcome Open Research 6, 2021 | 185 | 2021 |
Neutralising capacity against Delta (B. 1.617. 2) and other variants of concern following Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in health care workers, Israel Y Lustig, N Zuckerman, I Nemet, N Atari, L Kliker, G Regev-Yochay, ... Eurosurveillance 26 (26), 2100557, 2021 | 176 | 2021 |
Incidence of rash after amoxicillin treatment in children with infectious mononucleosis A Chovel-Sella, A Ben Tov, E Lahav, O Mor, H Rudich, G Paret, S Reif Pediatrics 131 (5), e1424-e1427, 2013 | 169 | 2013 |
Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1 I Levy, A Wieder-Finesod, V Litchevsky, A Biber, V Indenbaum, L Olmer, ... Clinical Microbiology and Infection 27 (12), 1851-1855, 2021 | 162 | 2021 |
Absence of p53 mutations in malignant mesotheliomas. O Mor, P Yaron, M Huszar, A Yellin, O Jakobovitz, F Brok-Simoni, ... American journal of respiratory cell and molecular biology 16 (1), 9-13, 1997 | 115 | 1997 |
Detection of SARS-CoV-2 variants by genomic analysis of wastewater samples in Israel I Bar-Or, M Weil, V Indenbaum, E Bucris, D Bar-Ilan, M Elul, N Levi, ... Science of The Total Environment 789, 148002, 2021 | 98 | 2021 |
New findings in HCV genotype distribution in selected West European, Russian and Israeli regions V Kartashev, M Döring, L Nieto, E Coletta, R Kaiser, S Sierra, A Guerrero, ... Journal of Clinical Virology 81, 82-89, 2016 | 86 | 2016 |
Initial real world evidence for lower viral load of individuals who have been vaccinated by BNT162b2 E Petter, O Mor, N Zuckerman, D Oz-Levi, A Younger, D Aran, Y Erlich MedRxiv, 2021.02. 08.21251329, 2021 | 81 | 2021 |
Nosocomial outbreak caused by the SARS-CoV-2 Delta variant in a highly vaccinated population, Israel, July 2021 P Shitrit, NS Zuckerman, O Mor, BS Gottesman, M Chowers Eurosurveillance 26 (39), 2100822, 2021 | 77 | 2021 |
Global and regional epidemiology of HIV-1 recombinants in 1990–2015: a systematic review and global survey J Hemelaar, R Elangovan, J Yun, L Dickson-Tetteh, S Kirtley, ... The Lancet HIV 7 (11), e772-e781, 2020 | 66 | 2020 |
Ongoing hepatitis A among men who have sex with men (MSM) linked to outbreaks in Europe in Tel Aviv area, Israel, December 2016–June 2017 Y Gozlan, I Bar-Or, A Rakovsky, M Savion, Z Amitai, R Sheffer, N Ceder, ... Eurosurveillance 22 (29), 30575, 2017 | 59 | 2017 |
Integrase strand transfer inhibitor (INSTI)-resistance mutations for the surveillance of transmitted HIV-1 drug resistance PL Tzou, SY Rhee, D Descamps, DS Clutter, B Hare, O Mor, M Grude, ... Journal of Antimicrobial Chemotherapy 75 (1), 170-182, 2020 | 58 | 2020 |
Evaluation of the RealTime HIV-1, Xpert HIV-1, and Aptima HIV-1 Quant Dx assays in comparison to the NucliSens EasyQ HIV-1 v2. 0 assay for quantification of HIV-1 viral load O Mor, Y Gozlan, M Wax, F Mileguir, A Rakovsky, B Noy, E Mendelson, ... Journal of clinical microbiology 53 (11), 3458-3465, 2015 | 57 | 2015 |
Testing IgG antibodies against the RBD of SARS-CoV-2 is sufficient and necessary for COVID-19 diagnosis V Indenbaum, R Koren, S Katz-Likvornik, M Yitzchaki, O Halpern, ... PloS one 15 (11), e0241164, 2020 | 56 | 2020 |
Missed opportunities for earlier diagnosis of HIV in patients who presented with advanced HIV disease: a retrospective cohort study I Levy, Y Maor, N Mahroum, L Olmer, A Wieder, V Litchevski, O Mor, ... BMJ open 6 (11), e012721, 2016 | 56 | 2016 |
Men who have sex with men, risk behavior, and HIV infection: integrative analysis of clinical, epidemiological, and laboratory databases I Levy, Z Mor, E Anis, S Maayan, E Leshem, S Pollack, M Chowers, O Mor, ... Clinical infectious diseases 52 (11), 1363-1370, 2011 | 49 | 2011 |